Fig. 8From: Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysisRisk of fractures with ICS/LABA therapy vs. Controls. (a: Risk of fractures with ICS/LABA therapy vs. Control; b: Risk of fractures with ICS/LABA therapy vs. LABA; c: Risk of fractures with ICS/LABA therapy vs. Placebo)Back to article page